|
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| EU Market Approval | EU |
| EU Designation Date | 2015-08-10 00:00:00 |
| Sponsor | Dr Ulrich Granzer |
